Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Aminoglycoside-induced vestibular injury: maintaining a sense of balance.

Ariano RE, Zelenitsky SA, Kassum DA.

Ann Pharmacother. 2008 Sep;42(9):1282-9. doi: 10.1345/aph.1L001. Epub 2008 Jul 22.

PMID:
18648019
2.

Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis.

Hatala R, Dinh T, Cook DJ.

Ann Intern Med. 1996 Apr 15;124(8):717-25.

PMID:
8633831
3.

Vestibular system in infants after systemic aminoglycoside therapy.

Zagólski O.

Int J Pediatr Otorhinolaryngol. 2007 Nov;71(11):1797-802. Epub 2007 Sep 17.

PMID:
17870186
4.

Vestibulotoxicity following aminoglycoside antibiotics and its prevention.

Darlington CL, Smith PF.

Curr Opin Investig Drugs. 2003 Jul;4(7):841-6. Review.

PMID:
14619406
5.

Aminoglycosides: assessing the potential for nephrotoxicity.

Wilson SE.

Surg Gynecol Obstet. 1990;171 Suppl:24-30. Review.

PMID:
2244292
6.

Vestibulotoxicity: a risk of home aminoglycoside therapy.

Saunders JE.

J Okla State Med Assoc. 2005 Dec;98(12):596-600.

PMID:
16425609
7.

Aminoglycoside-induced ototoxicity.

Selimoglu E.

Curr Pharm Des. 2007;13(1):119-26. Review.

PMID:
17266591
8.

Systemic ototoxicity: a review.

Shine NP, Coates H.

East Afr Med J. 2005 Oct;82(10):536-9. Review.

PMID:
16450683
9.

A critical reevaluation of the "therapeutic range" of aminoglycosides.

McCormack JP, Jewesson PJ.

Clin Infect Dis. 1992 Jan;14(1):320-39. Review.

PMID:
1571447
10.

Once-daily dosing of aminoglycosides: review and recommendations for clinical practice.

Freeman CD, Nicolau DP, Belliveau PP, Nightingale CH.

J Antimicrob Chemother. 1997 Jun;39(6):677-86. Review.

PMID:
9222035
11.

Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982.

Kahlmeter G, Dahlager JI.

J Antimicrob Chemother. 1984 Jan;13 Suppl A:9-22. Review.

PMID:
6365884
12.

Aminoglycoside ototoxicity.

Rizzi MD, Hirose K.

Curr Opin Otolaryngol Head Neck Surg. 2007 Oct;15(5):352-7. Review.

PMID:
17823553
13.

Aminoglycoside nephrotoxicity.

Swan SK.

Semin Nephrol. 1997 Jan;17(1):27-33. Review.

PMID:
9000547
14.

[Ototoxic drugs. I. Aminoglycoside antibiotics].

Buszman E, Wrześniok D, Matusiński B.

Wiad Lek. 2003;56(5-6):254-9. Review. Polish.

PMID:
14526485
15.

Randomized trials of aminoglycoside antibiotics: quantitative overview.

Buring JE, Evans DA, Mayrent SL, Rosner B, Colton T, Hennekens CH.

Rev Infect Dis. 1988 Sep-Oct;10(5):951-7. Review.

PMID:
3055193
16.

Hearing loss and vestibular dysfunction among children with cancer after receiving aminoglycosides.

Chen KS, Bach A, Shoup A, Winick NJ.

Pediatr Blood Cancer. 2013 Nov;60(11):1772-7. doi: 10.1002/pbc.24631. Epub 2013 Jun 20.

PMID:
23788258
17.

The evolution of aminoglycoside therapy: a single daily dose.

Deamer RL, Dial LK.

Am Fam Physician. 1996 Apr;53(5):1782-6. Review.

PMID:
8623702
18.
19.

Aminoglycosides--50 years on.

Begg EJ, Barclay ML.

Br J Clin Pharmacol. 1995 Jun;39(6):597-603. Review.

20.

Are vestibular hair cells excited to death by aminoglycoside antibiotics?

Smith PF.

J Vestib Res. 2000;10(1):1-5. Review.

PMID:
10798828

Supplemental Content

Support Center